FDA.reportPublic FDA data

safinamide 50 MG Oral Tablet

RxCUI
1922466
RxNorm name
safinamide 50 MG Oral Tablet
Display name
safinamide 50 MG Oral Tablet
Full name
safinamide 50 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XadagoSAFINAMIDE MESYLATEMDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.c4d65f28-983f-42b4-bb23-023ae0fe81b22025-10-22Warnings, Adverse reactionsExact identifier
rxcui: 1922466

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c4d65f28-983f-42b4-bb23-023ae0fe81b2safinamide 50 MG Oral Tablet [PSN] · safinamide 50 MG Oral Tablet [SCD] · safinamide 50 MG (as safinamide mesylate 65.88 MG) Oral Tablet [SY]320These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 201720251022